There exists an urgent need for effective treatments for those patients suffering from
chronic/progressive multiple sclerosis (MS). Accordingly, it has become readily apparent that …

Hematopoietic stem cell transplantation (HSCT) is a treatment paradigm that has long been
utilized for cancers of the blood and bone marrow but has gained some traction as a …

The complexity of multiple sclerosis (MS) and the incompetence of a large number of
promised treatments for MS urge us to plan new and more effective therapeutic approaches …

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system
characterized by demyelination and axonal degeneration. MS patients typically present with …

Stem cell transplantation holds great promise for restoration of neural function in various
neurodegenerative disorders, including multiple sclerosis (MS). However, many questions …

Multiple Sclerosis (MS) is a frequent demyelinating immune-mediated disease of the central
nervous system (CNS) that affects principally young adults and leads to severe physical and …

Multiple sclerosis (MS) is considered an inflammatory autoimmune disorder. Approved
immunotherapies are only moderately effective in reducing disease exacerbations and brain …

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous
system (CNS) which predominantly affect young adults and undergo heavy socioeconomic …

Multiple disease-modifying medications with regulatory approval to treat multiple sclerosis
(MS) are unable to prevent inflammatory tissue damage in the central nervous system …

Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system,
leading to significant disability through neurodegeneration. Despite advances in the …